STRATEC SE (SBS.DE) Stock Price, Forecast & Analysis

FRA:SBS • DE000STRA555

19.52 EUR
-0.4 (-2.01%)
Last: Feb 16, 2026, 10:03 AM

SBS.DE Key Statistics, Chart & Performance

Key Statistics
Market Cap237.36M
Revenue(TTM)257.62M
Net Income(TTM)16.02M
Shares12.16M
Float7.25M
52 Week High33.4
52 Week Low19.5
Yearly Dividend0.55
Dividend Yield3.06%
EPS(TTM)1.32
PE14.79
Fwd PE10.24
Earnings (Next)N/A
IPO1998-08-25
Sector
GICS SectorHealth Care
GICS IndustryHealth Care Equipment & Supplies
GICS IndustryGroupHealth Care Equipment & Services
GICS SubIndustryHealth Care Equipment
SBS.DE short term performance overview.The bars show the price performance of SBS.DE in the last week, last 2 weeks, last month, last 3 and 6 months. 1 week 2 week 1 month 3 months 6 months -5 -10 -15 -20

SBS.DE long term performance overview.The bars show the price performance of SBS.DE in the last 1, 2 and 3 years. 1 year 2 years 3 years -20 -40 -60

The current stock price of SBS.DE is 19.52 EUR. In the past month the price decreased by -16.48%. In the past year, price decreased by -39.91%.

STRATEC SE / SBS Daily stock chart

SBS.DE Technical Analysis


Chartmill TA Rating
Chartmill Setup Rating
SBS.DE Full Technical Analysis Report

SBS.DE Fundamental Analysis

ChartMill assigns a fundamental rating of 5 / 10 to SBS.DE. SBS.DE has an average financial health and profitability rating.


Chartmill FA Analysis
Valuation
Growth
Profitability
Health
Dividend
SBS.DE Full Fundamental Analysis Report

SBS.DE Financial Highlights

Over the last trailing twelve months SBS.DE reported a non-GAAP Earnings per Share(EPS) of 1.32. The EPS increased by 4.26% compared to the year before.


Industry RankSector Rank
PM (TTM) 6.22%
ROA 3.72%
ROE 6.67%
Debt/Equity 0.49
Chartmill High Growth Momentum
EPS Q2Q%173.23%
Sales Q2Q%-0.4%
EPS 1Y (TTM)4.26%
Revenue 1Y (TTM)-4.73%
SBS.DE financials

SBS.DE Forecast & Estimates

11 analysts have analysed SBS.DE and the average price target is 34.95 EUR. This implies a price increase of 79.04% is expected in the next year compared to the current price of 19.52.

For the next year, analysts expect an EPS growth of -11.28% and a revenue growth 1.41% for SBS.DE


Analysts
Analysts80
Price Target34.95 (79.05%)
EPS Next Y-11.28%
Revenue Next Year1.41%
SBS.DE Analyst EstimatesSBS.DE Analyst Ratings

SBS.DE Ownership

Ownership
Inst Owners37.43%
Ins OwnersN/A
Short Float %N/A
Short RatioN/A
SBS.DE Ownership

SBS.DE Competitors/Peers

The largest stocks on the EU markets in the "Health Care Equipment" sub-industry
Full List
SymbolCompany NameTechnical RatingFundamental RatingFPEMarket Cap
2M6 MEDTRONIC PLC16.35109.33B
SHL SIEMENS HEALTHINEERS AG15.245.887B
1PHIA KONINKLIJKE PHILIPS NV17.3825.46B
PHI1 KONINKLIJKE PHILIPS NV17.3625.431B
PHIA KONINKLIJKE PHILIPS NV17.1725.181B
BIM BIOMERIEUX18.410.978B
DIA DIASORIN SPA17.874.137B
OBCK OTTOBOCK SE & CO KGAA18.883.673B
1AFX CARL ZEISS MEDITEC AG - BR11.782.486B
AFX CARL ZEISS MEDITEC AG - BR11.242.399B

About SBS.DE

Company Profile

SBS logo image STRATEC SE engages in the design and manufacture of automated analyzer systems in the fields of clinical diagnostic and biotechnology. The company is headquartered in Birkenfeld, Baden-Wuerttemberg and currently employs 1,450 full-time employees. The firm is engaged in development and manufacture of analyzer systems, and it is also performing and managing administrative and organizational tasks for laboratory markets. Stratec is providing automation solutions and instrumentation of biochemical processes using hardware and software for in-vitro diagnostics and life science companies. The company also developing and integrating instrumentation, complex consumables and software by covering virtually the entire value chain for specification, design, manufacture and approval of complex analyzer system solutions.

Company Info

STRATEC SE

Gewerbestr. 37

BIRKENFELD BADEN-WUERTTEMBERG DE

Employees: 1462

SBS Company Website

SBS Investor Relations

Phone: 49708279160

STRATEC SE / SBS.DE FAQ

Can you describe the business of STRATEC SE?

STRATEC SE engages in the design and manufacture of automated analyzer systems in the fields of clinical diagnostic and biotechnology. The company is headquartered in Birkenfeld, Baden-Wuerttemberg and currently employs 1,450 full-time employees. The firm is engaged in development and manufacture of analyzer systems, and it is also performing and managing administrative and organizational tasks for laboratory markets. Stratec is providing automation solutions and instrumentation of biochemical processes using hardware and software for in-vitro diagnostics and life science companies. The company also developing and integrating instrumentation, complex consumables and software by covering virtually the entire value chain for specification, design, manufacture and approval of complex analyzer system solutions.


What is the current price of SBS stock?

The current stock price of SBS.DE is 19.52 EUR. The price decreased by -2.01% in the last trading session.


Does STRATEC SE pay dividends?

STRATEC SE (SBS.DE) has a dividend yield of 3.06%. The yearly dividend amount is currently 0.55.


How is the ChartMill rating for STRATEC SE?

SBS.DE has a ChartMill Technical rating of 0 out of 10 and a ChartMill Fundamental rating of 5 out of 10.


What is the analyst forecast for SBS.DE stock?

11 analysts have analysed SBS.DE and the average price target is 34.95 EUR. This implies a price increase of 79.04% is expected in the next year compared to the current price of 19.52.


What is the Price/Earnings (PE) ratio of STRATEC SE (SBS.DE)?

The PE ratio for STRATEC SE (SBS.DE) is 14.79. This is based on the reported non-GAAP earnings per share of 1.32 and the current share price of 19.52 EUR.


Can you provide the number of employees for STRATEC SE?

STRATEC SE (SBS.DE) currently has 1462 employees.